
dsm-firmenich
Swiss-Dutch nutrition, health, and beauty company formed by the 2023 merger of Royal DSM and Firmenich, listed on Euronext Amsterdam with approximately EUR 12.5 billion in 2025 sales.
Company Type
public
Founded
2023
Headquarters
Kaiseraugst, Switzerland (dual operational presence in Maastricht, Netherlands and Geneva, Switzerland)
Stock
Euronext Amsterdam: DSFIR
Revenue
EUR 12.52 billion total group (FY2025); EUR 9.03 billion continuing operations
Employees
Approximately 30,000
Primary Market
Global
About dsm-firmenich
Is dsm-firmenich a merger or acquisition?
dsm-firmenich was formed through a merger of equals between Royal DSM and Firmenich, completed May 9, 2023. It was structured as a merger rather than one company acquiring the other, with the Firmenich family retaining about a 34 percent stake.
Is dsm-firmenich publicly traded?
Yes. dsm-firmenich AG trades on Euronext Amsterdam under ticker DSFIR. The Firmenich family is the largest shareholder at roughly 34 percent, with the rest held by public investors.
When was dsm-firmenich formed?
The merged company was created in May 2023. Its predecessors are much older: Royal DSM dates to 1902 and Firmenich to 1895.
What does dsm-firmenich make?
It makes ingredients for nutrition, health, and beauty: fragrance and flavor compounds, vitamins, nutritional ingredients, and taste and texture solutions for food and beverage manufacturers. It operates primarily as a B2B supplier to consumer goods companies.
What is dsm-firmenich's market position?
dsm-firmenich is one of the world's largest ingredients companies, a top-four player in fragrance and flavor alongside Givaudan, Symrise, and IFF, with a broader nutrition business. FY2025 sales were EUR 12.5 billion.
Why did dsm-firmenich sell its animal nutrition business?
The company divested Animal Nutrition & Health to focus on higher-margin fragrance, beauty, taste, and health ingredients. It sold Feed Enzymes to Novonesis for EUR 1.5 billion in 2025 and agreed to sell the remaining ANH unit to CVC Capital Partners for about EUR 2.2 billion, announced February 2026.
History of dsm-firmenich
The modern company began in 2023, but its parents each bring more than a century of history. Royal DSM was founded in 1902 as the Dutch State Mines, a coal mining concern that transformed through petrochemicals into a life sciences and materials company over the 20th century. Firmenich was founded in 1895 in Geneva as a family-run perfume and flavor business that grew into one of the world's largest privately held fragrance houses.
The merger was announced in May 2022 and completed on May 9, 2023, combining DSM's nutrition and health science with Firmenich's perfumery and taste expertise. The deal was structured to create a company spanning fragrance, flavor, nutrition, and health in a single portfolio, with the Firmenich family remaining the largest shareholder through a roughly 34 percent stake.
The first two years were dominated by integration and portfolio rationalization. In 2025 the company sold its Feed Enzymes business to Novonesis for EUR 1.5 billion, and in February 2026 it announced an agreement to divest the remainder of its Animal Nutrition & Health unit to CVC Capital Partners for approximately EUR 2.2 billion in enterprise value, retaining a 20 percent stake. The ANH divestment triggered the EUR 1.9 billion impairment that drove the 2025 reported net loss.
With the animal nutrition exit largely complete by 2026, dsm-firmenich positions itself as a pure-play consumer ingredients company, focused on Perfumery & Beauty, Taste, Texture & Health, and Health, Nutrition & Care, targeting mid-single-digit organic growth and margin expansion under CEO Dimitri de Vreeze.
dsm-firmenich Sustainability & Ethics
Sustainability is central to dsm-firmenich's positioning, inherited from both parents' strong ESG records. The company holds science-based emissions targets and reports detailed progress on renewable energy, sustainable sourcing, and product-level environmental footprinting.
Flagship sustainability products include Bovaer, which reduces cattle methane emissions, and the company's natural and bio-based ingredient lines. DSM historically ranked among the world's most sustainable companies, and dsm-firmenich maintains that orientation in its public reporting, though it is not B Corp certified.
Controversy, Regulation & Public Scrutiny
dsm-firmenich has faced no major scandal as a merged entity, though its businesses carry the regulatory complexity of chemicals, food, and health ingredients. Vitamin pricing has drawn antitrust attention to the broader industry historically, and predecessor DSM was part of earlier vitamin cartel settlements decades ago.
The large 2025 impairment tied to the ANH divestment drew investor scrutiny over merger execution, and integration costs have been a persistent analyst focus. Regulatory compliance across food safety, chemical regulation, and health claims in its many markets remains an ongoing operational responsibility.
Brands Owned by dsm-firmenich
dsm-firmenich owns 0 brands in our database. Explore the ownership tree below — click categories to expand and see individual brands.
dsm-firmenich has no brands in our database yet.
Stock Information
dsm-firmenich Ownership: Pros & Cons
Advantages
- +Top-tier position in fragrance, flavor, and nutrition ingredients
- +Higher-margin focus after ANH divestment
- +Firmenich family stake provides long-term alignment
- +Strong sustainability and innovation credentials
- +Bovaer and natural ingredient platforms support growth
Considerations
- -Large 2025 impairment reflected merger integration costs
- -Flat continuing-operations growth in 2025
- -Concentrated family ownership limits float
- -Intense competition from Givaudan, Symrise, and IFF
- -Execution risk during portfolio transformation
Frequently Asked Questions About dsm-firmenich
Is dsm-firmenich a merger or acquisition?
dsm-firmenich was formed through a merger of equals between Royal DSM and Firmenich, completed May 9, 2023. It was structured as a merger rather than one company acquiring the other, with the Firmenich family retaining about a 34 percent stake.
Is dsm-firmenich publicly traded?
Yes. dsm-firmenich AG trades on Euronext Amsterdam under ticker DSFIR. The Firmenich family is the largest shareholder at roughly 34 percent, with the rest held by public investors.
When was dsm-firmenich formed?
The merged company was created in May 2023. Its predecessors are much older: Royal DSM dates to 1902 and Firmenich to 1895.
What does dsm-firmenich make?
It makes ingredients for nutrition, health, and beauty: fragrance and flavor compounds, vitamins, nutritional ingredients, and taste and texture solutions for food and beverage manufacturers. It operates primarily as a B2B supplier to consumer goods companies.
What is dsm-firmenich's market position?
dsm-firmenich is one of the world's largest ingredients companies, a top-four player in fragrance and flavor alongside Givaudan, Symrise, and IFF, with a broader nutrition business. FY2025 sales were EUR 12.5 billion.
Why did dsm-firmenich sell its animal nutrition business?
The company divested Animal Nutrition & Health to focus on higher-margin fragrance, beauty, taste, and health ingredients. It sold Feed Enzymes to Novonesis for EUR 1.5 billion in 2025 and agreed to sell the remaining ANH unit to CVC Capital Partners for about EUR 2.2 billion, announced February 2026.






